Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B H Warrington

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Pharmacy and Pharmacology|September 1, 1976
The enolization of 4,5-dehydromuscaroneA H Beckett, B H Warrington, R Griffiths
Journal of Computer-Aided Molecular Design|July 1, 1987
Strategic approaches to drug design. II. Modelling studies on phosphodiesterase substrates and inhibitorsA Davis, B H Warrington, J G Vinter
Biochemical Pharmacology|December 15, 1992
8-(4-Chlorophenyl)thio-cyclic AMP is a potent inhibitor of the cyclic GMP-specific phosphodiesterase (PDE VA)B J Connolly, P B Willits, B H Warrington, et al.
Journal of Medicinal Chemistry|June 1, 1990
1,4-bis(3-oxo-2,3-dihydropyridazin-6-yl)benzene analogues: potent phosphodiesterase inhibitors and inodilatorsW J Coates, H D Prain, M L Reeves, et al.
Ernst Schering Foundation Symposium Proceedings|August 19, 2007
Microreactors as new tools for drug discovery and developmentS Y F Wong-Hawkes, J C Matteo, B H Warrington, et al.
Acta Crystallographica. Section B, Structural Science|February 1, 1994
Crystal and molecular structures of pyridazinone cardiovascular agentsK Prout, C Bannister, K Burns, et al.
The Analyst|February 24, 2001
The generation of concentration gradients using electroosmotic flow in micro reactors allowing stereoselective chemical synthesisV Skelton, G M Greenway, S J Haswell, et al.
British Journal of Pharmacology|April 1, 1994
Pulmonary effects of type V cyclic GMP specific phosphodiesterase inhibition in the anaesthetized guinea-pigN C Turner, J S Dolan, D Grimsditch, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Pharmacy and Pharmacology|September 1, 1976
The enolization of 4,5-dehydromuscaroneA H Beckett, B H Warrington, R Griffiths
Journal of Computer-Aided Molecular Design|July 1, 1987
Strategic approaches to drug design. II. Modelling studies on phosphodiesterase substrates and inhibitorsA Davis, B H Warrington, J G Vinter
Biochemical Pharmacology|December 15, 1992
8-(4-Chlorophenyl)thio-cyclic AMP is a potent inhibitor of the cyclic GMP-specific phosphodiesterase (PDE VA)B J Connolly, P B Willits, B H Warrington, et al.
Journal of Medicinal Chemistry|June 1, 1990
1,4-bis(3-oxo-2,3-dihydropyridazin-6-yl)benzene analogues: potent phosphodiesterase inhibitors and inodilatorsW J Coates, H D Prain, M L Reeves, et al.
Ernst Schering Foundation Symposium Proceedings|August 19, 2007
Microreactors as new tools for drug discovery and developmentS Y F Wong-Hawkes, J C Matteo, B H Warrington, et al.
Acta Crystallographica. Section B, Structural Science|February 1, 1994
Crystal and molecular structures of pyridazinone cardiovascular agentsK Prout, C Bannister, K Burns, et al.
The Analyst|February 24, 2001
The generation of concentration gradients using electroosmotic flow in micro reactors allowing stereoselective chemical synthesisV Skelton, G M Greenway, S J Haswell, et al.
British Journal of Pharmacology|April 1, 1994
Pulmonary effects of type V cyclic GMP specific phosphodiesterase inhibition in the anaesthetized guinea-pigN C Turner, J S Dolan, D Grimsditch, et al.
Pageof 1